Form 4 for EWTX Edgewise Therapeutics, Inc.
Accepted 2023-12-28 00:00:00 ET · period of report 2023-12-27 · accession 0001562180-23-008572 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-28 | 2023-12-27 | EWTX | MOORE JOHN R | GC | S - Sale | $10.50 | -8,497 | 0 | -100% | -$89.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-27 | S | D | 8,497 | $10.50 | 0 | D | — | — | (F2) Includes 1,932 shares purchased on May 15, 2023 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan. |